Der Nephrologe

, Volume 8, Issue 1, pp 37–42 | Cite as

Phosphat und Nahrung



Bei Dialysepatienten sind hohe Phosphatzufuhr und Hyperphosphatämie verknüpft mit erhöhtem kardiovaskulären Risiko und gesteigerter Mortalität. Neben dem Einsatz von Phosphatbindern oder Hemmern der intestinalen Phosphatabsorption kommt daher der Vermeidung hoher Phosphatzufuhr in Lebensmitteln große Bedeutung zu. Neben dem in Lebensmitteln vorhandenen organisch gebundenen Phosphat (welches nur teilweise absorbiert wird) spielt zunehmend Phosphat als Lebensmittelzusatz eine wichtige Rolle. Die Abschätzung der Phosphatzusätze in kommerziellen Lebensmitteln wird erschwert durch fehlende Angaben zum Phosphatgehalt. Umso wichtiger ist die Schulung und Aufklärung nierenkranker Patienten zur Abschätzung des Phosphatgehalts in Nahrungsmitteln.


Dialysepatienten Hyperphosphatämie Phosphatgehalt in Nahrungsmitteln Intestinale Phosphatabsorption Phosphatbinder 

Phosphate and nutrition


In patients with advanced chronic kidney disease (CKD) and in patients on dialysis high phosphate intake and hyperphosphatemia are associated with increased cardiovascular risk and increased mortality. Apart from phosphate binders and inhibitors of intestinal phosphate absorption, it is important to avoid high dietary phosphate intake, specifically phosphate-enriched food items. Apart from phosphate bound by organic molecules (which is less avidly absorbed in the gut), inorganic phosphate added for various reasons to food items, plays an increasingly important role. Because it is not legally required to indicate added phosphate in commercial food items it is very difficult for patients to assess the effective (actual) phosphate content. Against this background it is important to educate patients with CKD to be able to estimate the phosphate content in food items and to avoid high phosphate nutrients.


Dialysis patients Hyperphosphatemia Phosphate content in food items Intestinal phosphate uptake Phosphate binders 


  1. 1.
    Kestenbaum B, Sampson JN, Rudser KD et al (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16(2):520–528PubMedCrossRefGoogle Scholar
  2. 2.
    Noori N, Kalantar-Zadeh K, Kovesdy CP et al (2010) Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol 5(4):683–692PubMedCrossRefGoogle Scholar
  3. 3.
    Dhingra R, Sullivan LM, Fox CS et al (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167(9):879–885PubMedCrossRefGoogle Scholar
  4. 4.
    Sandberg AS, Andersson H, Kivistö B, Sandström B (1986) Extrusion cooking of a high-fibre cereal product. 1. Effects on digestibility and absorption of protein, fat, starch, dietary fibre and phytate in the small intestine. Br J Nutr 55(2):245–254PubMedCrossRefGoogle Scholar
  5. 5.
    Sullivan C, Sayre SS, Leon JB et al (2009) Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA 301(6):629–635PubMedCrossRefGoogle Scholar
  6. 6.
    Moe SM, Zidehsarai MP, Chambers MA et al (2011) Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol 6(2):257–264PubMedCrossRefGoogle Scholar
  7. 7.
    Boaz M, Smetana S (1996) Regression equation predicts dietary phosphorus intake from estimate of dietary protein intake. J Am Diet Assoc 96(12):1268–1270PubMedCrossRefGoogle Scholar
  8. 8.
    Uribarri J (2007) Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial 20(4):295–301PubMedCrossRefGoogle Scholar
  9. 9.
    Murphy-Gutekunst L (2005) Hidden phosphorus in popular beverages. Nephrol Nurs J 32(4):443–445PubMedGoogle Scholar
  10. 10.
    Chue CD, Edwards NC, Moody WE et al (2012) Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: a cardiac magnetic resonance study. Heart 98(3):219–224PubMedCrossRefGoogle Scholar
  11. 11.
    Uribarri J, Calvo MS (2003) Hidden sources of phosphorus in the typical American diet: does it matter in nephrology? Semin Dial 16(3):186–188PubMedCrossRefGoogle Scholar
  12. 12.
    Ohnishi M, Razzaque MS (2010) Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J 24(9):3562–3571PubMedCrossRefGoogle Scholar
  13. 13.
    Ellam TJ, Chico TJ (2012) Phosphate: the new cholesterol? The role of the phosphate axis in non-uremic vascular disease. Atherosclerosis 220(2):310–318PubMedCrossRefGoogle Scholar
  14. 14.
    Zoccali C, Ruggenenti P, Perna A et al (2011) Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. J Am Soc Nephrol 22(10):1923–1930PubMedCrossRefGoogle Scholar
  15. 15.
    Wahl P, Xie H, Scialla J et al (2012) Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease. Diabetes Care 35(5):994–1001PubMedCrossRefGoogle Scholar
  16. 16.
    Benavente D, Chue CD, Moore J et al (2012) Serum phosphate measured at 6 and 12 months after successful kidney transplant is independently associated with subsequent graft loss. Exp Clin Transplant 10(2):119–124PubMedCrossRefGoogle Scholar
  17. 17.
    Di Iorio B, Bellasi A, Russo D; INDEPENDENT Study Investigators (2012) Mortality in kidney disease patients treated with phosphate binders: a randomized study. Clin J Am Soc Nephrol 7(3):487–493CrossRefGoogle Scholar
  18. 18.
    Kalantar-Zadeh K, Gutekunst L, Mehrotra R et al (2010) Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 5(3):519–530PubMedCrossRefGoogle Scholar
  19. 19.
    Sherman RA, Mehta O (2009) Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol 4(8):1370–1373PubMedCrossRefGoogle Scholar
  20. 20.
    Wyshak G (2000) Teenaged girls, carbonated beverage consumption, and bone fractures. Arch Pediatr Adolesc Med 154(6):610–613PubMedCrossRefGoogle Scholar
  21. 21.
    Isakova T, Gutierrez O, Shah A et al (2008) Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol 19(3):615–623PubMedCrossRefGoogle Scholar
  22. 22.
    Parker BD, Schurgers LJ, Brandenburg VM et al (2010) The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med 152(10):640–648PubMedGoogle Scholar
  23. 23.
    Fliser D, Kollerits B, Neyer U et al (2007) Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 18(9):2600–2608PubMedCrossRefGoogle Scholar
  24. 24.
    Isakova T, Xie H, Yang W et al (2011) Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 305(23):2432–2439PubMedCrossRefGoogle Scholar
  25. 25.
    Gutierrez OM, Mannstadt M, Isakova T et al (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359(6):584–592PubMedCrossRefGoogle Scholar
  26. 26.
    Hsu HJ, Wu MS (2009) Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients. Am J Med Sci 337(2):116–122PubMedCrossRefGoogle Scholar
  27. 27.
    Gutiérrez OM, Anderson C, Isakova T et al (2010) Low socioeconomic status associates with higher serum phosphate irrespective of race. J Am Soc Nephrol 21(11):1953–1960PubMedCrossRefGoogle Scholar
  28. 28.
    Shinaberger CS, Kilpatrick RD, Regidor DL et al (2006) Longitudinal associations between dietary protein intake and survival in hemodialysis patients. Am J Kidney Dis 48(1):37–49PubMedCrossRefGoogle Scholar
  29. 29.
    National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 Suppl 3):S1–S201Google Scholar
  30. 30.
    Sherman RA, Mehta O (2009) Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis 54(1):18–23PubMedCrossRefGoogle Scholar
  31. 31.
    Ketteler M, Westenfeld R, Ritz E (2012) Not all phosphate is created equal. J Ren Nutr 22(6):592–595PubMedCrossRefGoogle Scholar
  32. 32.
    Bommer J, Ketteler M, Ritz E (2012) Impact of oral calcium on mortality of dialysis patients – an underestimated risk? Nephrol Dial Transplant 27(7):2628–2633PubMedCrossRefGoogle Scholar
  33. 33.
    Martin KJ, Gonzalez EA (2011) Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat? Clin J Am Soc Nephrol 6(2):440–446PubMedCrossRefGoogle Scholar
  34. 34.
    Isakova T, Gutiérrez OM, Chang Y et al (2009) Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol 20(2):388–396PubMedCrossRefGoogle Scholar
  35. 35.
    Cupisti A, Morelli E, D’Alessandro C et al (2003) Phosphate control in chronic uremia: don’t forget diet. J Nephrol 16(1):29–33PubMedGoogle Scholar
  36. 36.
    Gardulf A, Palsson M, Nicolay U (2011) Education for dialysis patients lowers long-term phosphate levels and maintains health-related quality of life. Clin Nephrol 75(4):319–327PubMedGoogle Scholar
  37. 37.
    Kuhlmann MK (2007) Practical approaches to management of hyperphosphatemia: can we improve the current situation? Blood Purif 25(1):120–124PubMedCrossRefGoogle Scholar
  38. 38.
    Ahlenstiel T, Pape L, Ehrich JH, Kuhlmann MK (2010) Self-adjustment of phosphate binder dose to meal phosphorus content improves management of hyperphosphataemia in children with chronic kidney disease. Nephrol Dial Transplant 25(10):3241–3249PubMedCrossRefGoogle Scholar
  39. 39.
    Ritz E, Hahn K, Ketteler M et al (2012) Phosphate additives in food – a health risk. Dtsch Arztebl Int 109(4):49–55PubMedGoogle Scholar
  40. 40.
    Faul C, Amaral AP, Oskouei B et al (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121(11):4393–4408PubMedCrossRefGoogle Scholar
  41. 41.
    Sehgal A (2011) Food additives: a hidden and preventable source of hyperphosphatemia. ASN Kidney WeekGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  1. 1.Nephrologische Gemeinschaftspaxis/DialyseDortmundDeutschland
  2. 2.Vivantes Klinikum im FriedrichshainBerlinDeutschland
  3. 3.NierenzentrumHeidelbergDeutschland

Personalised recommendations